13F Holdings
中文EN

PDEX PRO DEX INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 788920 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.3%
TTM net income YoY7.5%
TTM EPS YoY9.6%
Revenue 3-yr CAGR19.2%
Net income 3-yr CAGR16.7%

Margins

Gross margin32.5%
Operating margin16.8%
Net margin15.1%
FCF margin13.4%
EBITDA margin18.7%

Returns

ROE26.5%
ROA17.1%
ROIC (approx.)27.0%
Asset turnover1.13x

Leverage & solvency

Liabilities / assets35.6%
Debt / equity0.00x
Current ratio4.19x
Interest coverage15.36x

Cash quality & payout

Operating cash flow / net income0.95x
Accruals ratio0.9%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$20.56M$20.41M$19.95M$18.66M$18.53M$17.49M$17.41M$16.79M
Cost of revenue$13.70M$13.31M$13.82M$12.92M$13.16M$14.00M$11.62M$11.72M
Gross profit$6.86M$7.09M$6.13M$5.74M$5.37M$3.49M$5.80M$5.07M
R&D expense$1.21M$1.02M$827,000$734,000$768,000$905,000$947,000$942,000
SG&A expense$2.13M$2.54M$2.21M$1.75M$1.49M$1.24M$1.21M$1.44M
Operating income$3.52M$3.53M$3.09M$3.26M$3.11M$1.34M$3.64M$2.69M
Interest expense$260,000$270,000$201,000$141,000$200,000$227,000$246,000$204,000
Pretax income$3.38M$3.52M$5.34M$2.93M$6.22M$1.60M$4.55M$2.59M
Income tax$331,000$668,000$1.40M$741,000$1.54M$402,000$1.28M$546,000
Net income$3.05M$2.86M$3.94M$2.19M$4.68M$1.20M$3.27M$2.04M
EBITDA$3.92M$3.94M$3.46M$3.57M$3.42M$1.66M$3.66M$3.00M
EPS (basic)0.95—1.230.671.43—1.000.63
EPS (diluted)0.92—1.200.661.40—0.980.61
Weighted avg. shares (diluted)3.32M—3.27M3.30M3.34M—3.34M3.34M
Balance sheet
Cash & equivalents$11.76M$8.19M$6.63M$5.27M$514,000$419,000$4.47M$66,000
Short-term investments$1.23M$1.15M$986,000$864,000$10.04M$6.74M$5.42M$4.67M
Receivables$17.51M$21.20M$19.47M$17.88M$18.23M$16.43M$15.86M$18.47M
Inventory$21.90M$21.46M$22.36M$21.71M$21.56M$22.21M$23.43M$19.61M
Current assets$53.95M$53.25M$53.71M$49.19M$50.72M$47.30M$49.94M$44.30M
PP&E, net$5.36M$5.37M———$5.15M$6.08M$6.11M
Goodwill$6.53M$6.53M$6.53M—————
Intangibles$666,000$686,000$712,000$12,000$19,000$26,000$33,000$40,000
Total assets$76.59M$74.51M$74.98M$62.26M$64.30M$61.19M$64.27M$60.37M
Current liabilities$12.88M$12.98M$14.64M$12.20M$13.60M$14.63M$18.32M$17.14M
Long-term debt—$17.51M———$15.43M——
Total debt—$17.51M———$15.43M——
Total liabilities$27.24M$26.88M$29.78M$20.62M$22.79M$24.56M$28.99M$28.55M
Shareholders' equity$49.35M$47.63M$45.20M$41.61M$41.51M$36.63M$35.28M$31.82M
Net debt—$9.32M———$15.01M——
Shares outstanding3.20M3.19M3.20M3.21M3.26M3.26M3.26M3.26M
Cash flow statement
Operating cash flow$6.49M-$273,000$1.63M$3.57M$2.31M-$173,000$754,000-$4.15M
Capital expenditure$346,000$203,000$112,000$70,000$98,000$93,000$180,000$542,000
Free cash flow$6.14M-$476,000$1.52M$3.50M$2.21M-$266,000$574,000-$4.69M
Investing cash flow-$346,000$198,000-$5.05M$8.87M-$98,000-$992,000$1.73M-$542,000
Financing cash flow-$2.58M-$1.73M$5.46M-$5.00M-$2.12M-$2.89M$1.93M$1.68M
Depreciation & amortization$403,000$406,000$363,000$314,000$311,000$314,000$23,000$313,000
Stock-based compensation$135,000$177,000$186,000$164,000$161,000$154,000$158,000$130,000
Share buybacks$600,000$600,000$601,000——$0$0$1.19M

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.